Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

305
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : J&J in $4 Billion Settlement Talks

11/12/2013 | 05:16pm US/Eastern

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to nymonitoring@dowjones.com

React to this article
Latest news on JOHNSON & JOHNSON
07/07DJP&G Settles Suit on Puffed-Up Packaging
07/07 JOHNSON & JOHNSON : STELARA® Receives European Commission Approval for Treatment..
07/07 JOHNSON & JOHNSON : SIMPONI® Receives European Commission Approval for Treatment..
07/07 JOHNSON & JOHNSON : Xarelto Injury Lawsuits Publishes New Examination of Mountin..
07/07 Horizon Pharma goes hostile with $3 billion offer for Depomed
07/07DJHorizon Pharma Offers to Buy Depomed for $1.75 Billion
07/06 JOHNSON & JOHNSON : Daratumumab Expanded Access Program Open to Eligible U.S. Pa..
07/06 GILEAD SCIENCES : Submits New Drug Application to U.S. FDA for Single Tablet Reg..
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/03 China's Li Ning says vice-chairman Kim resigns, names new director
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials